In the upper digestive system, RBM3 is highly expressed in esophageal and gastric adenocarcinoma, and reduced RBM3 expression is an independent factor of reduced overall and recurrence-free survival in these patients. The gene discussed is RBM3; the disease is gastric adenocarcinoma.